Pitcairn’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.89M | Sell |
8,637
-3,991
| -32% | -$873K | 0.12% | 153 |
|
|
2025
Q1 | $2.83M | Buy |
12,628
+5,126
| +68% | +$1.15M | 0.17% | 113 |
|
|
2024
Q4 | $2.46M | Buy |
7,502
+2,263
| +43% | +$741K | 0.15% | 127 |
|
|
2024
Q3 | $1.57M | Buy |
5,239
+4,328
| +475% | +$1.3M | 0.09% | 201 |
|
|
2024
Q2 | $300K | Buy |
911
+36
| +4% | +$11.9K | 0.02% | 587 |
|
|
2024
Q1 | $346K | Buy |
875
+29
| +3% | +$11.5K | 0.02% | 539 |
|
|
2023
Q4 | $298K | Sell |
846
-19
| -2% | -$6.69K | 0.02% | 540 |
|
|
2023
Q3 | $325K | Sell |
865
-21
| -2% | -$7.88K | 0.03% | 478 |
|
|
2023
Q2 | $339K | Sell |
886
-5
| -0.6% | -$1.91K | 0.03% | 480 |
|
|
2023
Q1 | $309K | Sell |
891
-22
| -2% | -$7.62K | 0.03% | 485 |
|
|
2022
Q4 | $215K | Buy |
913
+57
| +7% | +$13.4K | 0.02% | 551 |
|
|
2022
Q3 | $211K | Sell |
856
-44
| -5% | -$10.8K | 0.02% | 541 |
|
|
2022
Q2 | $272K | Sell |
900
-9
| -1% | -$2.72K | 0.03% | 464 |
|
|
2022
Q1 | $373K | Sell |
909
-12
| -1% | -$4.92K | 0.03% | 447 |
|
|
2021
Q4 | $432K | Sell |
921
-197
| -18% | -$92.4K | 0.03% | 410 |
|
|
2021
Q3 | $475K | Sell |
1,118
-44
| -4% | -$18.7K | 0.03% | 363 |
|
|
2021
Q2 | $417K | Buy |
1,162
+109
| +10% | +$39.1K | 0.03% | 404 |
|
|
2021
Q1 | $297K | Buy |
1,053
+13
| +1% | +$3.67K | 0.02% | 493 |
|
|
2020
Q4 | $294K | Buy |
1,040
+177
| +21% | +$50K | 0.02% | 448 |
|
|
2020
Q3 | $237K | Sell |
863
-38
| -4% | -$10.4K | 0.02% | 442 |
|
|
2020
Q2 | $204K | Buy |
+901
| New | +$204K | 0.02% | 466 |
|